Decision/Regulate/
Adopted
NPPA caps trade margin on 137 anti-cancer non-scheduled drugs at 30% of MRP
India's NPPA capped trade margins on 137 non-scheduled anti-cancer drugs, including patented ones, at 30% of MRP, which companies say will sharply cut prices and save patients money.
Actors and targets
Targets 30% ट्रेड मार्जिन कैपpolicyकैंसर-रोधी 137 गैर-अनुसूचित (non-scheduled) दवाओंitem
Source
17 अक्टूबर 2026 को, नेशनल फार्मास्युटिकल प्राइसिंग अथॉरिटी (NPPA) ने कैंसर-रोधी 137 गैर-अनुसूचित (non-scheduled) दवाओं - जिनमें पेटेंट वाली दवाएं भी शामिल हैं - पर ट्रेड मार्जिन को अधिकतम खुदरा मूल्य (MRP) के 30% तक सीमित कर दिया है।
Not established
- Date known only to the year
- Effective date of the margin cap
- Penalty or enforcement mechanism for non-compliance
- Duration of the cap
Extracted detail
- Decision maker
- National Pharmaceutical Pricing Authority (NPPA)
- Country
- India
Related decisions
Same kind only, ranked by embedding similarity to this record.